A Dose Escalation Study of Intravenous L-citrulline in Steady-state Sickle Cell Disease

Clinical trial NCT02314689 · COMPLETED

Trial details

NCT number: NCT02314689
Sponsor: Suvankar Majumdar
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2015-01-01
Primary completion: 2015-12-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.